• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    Journal of Pathology

    Journal of Pathology

    JournalISSN 0022-3417eISSN 1096-9896中科院 医学 2区

    年发文量

    研究主题

    论文(220359)

    排序
    1NewThe P. Ser143Pro Lamin A/C Mutation Leads to Dilated Cardiomyopathy and Activates the Unfolded Protein Response Pathway in a Knock‐in Mouse Model
    Fanny Lindholm,Gun West,Laura Virtanen, Laura Kähäri, Mia Ståhle, Wail Nammas,Carl‐Gustaf A Stenvall, Maria Bouvy‐Liivrand, Fu‐Ping Zhang,Petra Sipilä, Maria Gardberg,Diana M Toivola,

    Abstract Dilated cardiomyopathy (DCM) is characterized by progressive ventricular dilation, systolic dysfunction, and an increased risk of arrythmias and sudden cardiac arrest. Variants in the LMNA gene, which encodes the nuclear lamins A and C, have been linked to the familial form of the disease and the founder variant p.Ser143Pro is particularly common among Finnish patients with DCM. To elucidate the complex and poorly understood pathogenic mechanisms behind LMNA ‐related DCM, we generated a mouse model carrying the p.Ser143Pro mutation in the Lmna gene. All genetically modified mice appeared normal at birth. However, based on echocardiography, necropsy, natriuretic peptide B ( Nppb ) expression levels, and histopathological data, homozygous males developed progressive left ventricular dilatation, myocardial fibrosis, and cardiac failure after 6 months of age, with all succumbing before 10 months. A reduced disease penetrance was observed in heterozygous male and homozygous female mice, with one‐year survival rates of 40% and 60%, respectively. No signs of skeletal myopathy were observed in mice carrying the mutation. Whole‐transcriptome RNA sequencing analysis of left ventricular cardiac tissue from asymptomatic two‐month‐old homozygous male mice revealed an upregulation of classical heart failure markers, such as natriuretic peptide A ( Nppa ) and myosin heavy chain 7 ( Myh7 ), and an elevated unfolded protein response signaling, as shown by elevated DNA damage inducible transcript 3 ( Ddit3 ), BAG cochaperone 3 ( Bag3 ) and CCAAT enhancer binding protein beta ( Cebpb ) levels. In conclusion, p.Ser143Pro‐ Lmna mice closely mimic the clinical phenotype observed in patients with the p.Ser143Pro LMNA variant and offer a valuable in vivo model for investigating the underlying pathogenic mechanisms of LMNA ‐related DCM. © 2026 The Author(s). The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.

    2026
    引用
    AI阅读
    加入学术空间
    2NewSpatial Transcriptomics Reveal Depth‐dependent Nerve Growth Factor and M2 ‐like Macrophage Enrichment in the Perineural Invasion of Distal Cholangiocarcinoma
    Kenta Ogasawara,Tadashi Yoshizawa, Keno Kudo, Michi Izawa, Yoshiki Nishiyama,Shintaro Goto,Daiki Kasai,Hirokazu Ogasawara,Satoru Tsuruta,Yusuke Wakasa,Hayato Nagase,Taiichi Wakiya,

    Perineural invasion (PNI) is a frequent pathological feature of distal cholangiocarcinoma. The spatial molecular programs associated with PNI are unclear. We aimed to characterize tumor–nerve–immune interactions linked to PNI using spatial transcriptomics and independent validation. Spatial transcriptomics was performed using GeoMx Digital Spatial Profiler on six cases of surgically resected distal cholangiocarcinoma (non‐PNI, n = 3; PNI, n = 3). Regions of interest included non‐PNI tumor regions, surface mucosal tumor regions without neural contact (PNI‐surface), and tumor regions adjacent to S100‐positive nerves (PNI‐perineural). Tumor compartments were enriched by CK19‐based segmentation. Differential expression and pathway analyses were performed using iDEP/DESeq2 and Reactome/Kyoto Encyclopedia of Genes and Genomes enrichment. Validation at the protein level was conducted using immunohistochemistry in an independent cohort (non‐PNI, n = 22 and PNI, n = 82) for nerve growth factor (NGF), CD68, and CD163. Three‐dimensional nerve architecture was assessed in nine additional cases using tissue clearing. PNI‐associated compartments and non‐PNI regions had distinct transcriptional profiles. Compared to that in non‐PNI, 109 genes were differentially expressed in PNI‐surface (34 up‐ and 75 downregulated) and 179 in PNI‐perineural (64 up‐ and 115 downregulated). Pathway analyses identified enrichment of immune‐, microenvironment‐, and neurotrophic‐related programs, including NGF‐associated signatures. Tumor‐cell NGF expression was significantly higher in PNI‐positive tumors (median H ‐score: 215 versus 119, p < 0.0001) and increased with depth in PNI cases ( p < 0.0001). Deep invasive regions of PNI‐positive tumors saw a significant increase in CD68‐positive (median 313 versus 210 cells per high‐power field, p < 0.001) and CD163‐positive (median 64 versus 40 cells per high‐power field, p < 0.01) macrophages. CD163/CD68 ratio increased in deep versus surface regions, specifically in PNI‐positive tumors ( p < 0.0001). PNI‐positive distal cholangiocarcinoma exhibited spatially distinct tumor programs and depth‐dependent remodeling involving NGF upregulation and M2‐like macrophage enrichment, identifying potential therapeutic targets. © 2026 The Author(s). The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.

    2026
    引用
    AI阅读
    加入学术空间
    3NewPEG10is a Candidate Biomarker for Malignant Tumors Occurring Indicer1-Related Tumor Predisposition
    Mona K. Wu,Felix K. F. Kommoss,Jemily Malvar,Yueh-Yun Chi,Lili Fu,William D. Foulkes,James F. Amatruda

    Children with germline pathogenic variants of DICER1 have a highly elevated risk of cancers in many different organs, recognized as DICER1-related tumor predisposition (DRTP). DRTP tumors/lesions have one inactivated copy and one 'hotspot' mutated copy of DICER1. All 'hotspot' DICER1 mutations impair 5p microRNA (miRNA) production. MiRNAs are short non-coding RNA molecules that downregulate messenger RNA (mRNA) expression. Mature 5p or 3p miRNAs are produced by the endonuclease DICER1. Mature miRNAs are loaded into AGO2-containing RNA-induced silencing complex where they target mRNAs via a seed sequence in the mRNA's 3' untranslated region (3' UTR). Despite evidence of widespread dysregulation of gene expression in the presence of DICER1 'hotspot' mutations, there is no established immunohistochemistry (IHC) marker to complement sequencing-based strategies for identification of DRTP tumors. AGO2 miR-eCLIP and RNA-seq data from a mouse cell model of DRTP (Dicer1 E1705K, referred to here as E1705K cells) identified paternally expressed gene 10 (Peg10) as a diagnostic candidate. Peg10 mRNA and protein expression were tested in control and Dicer1-mutant cells, and de-repression of Peg10 3' UTR was tested using reporter assays. PEG10 IHC staining of a human tumor microarray (TMA, n = 63) was performed and the performance of the PEG10 H-score as a DICER1 classifier was evaluated using receiver operating characteristic (ROC) analysis. Peg10 mRNA and protein levels were elevated in E1705K cells. Expression of a reporter gene linked to the Peg10 3' UTR was elevated in mutant but not control cells, consistent with altered miRNA regulation of Peg10 in the mutant cells. A PEG10 H-score cutoff of 35 resulted in a sensitivity of 78.1% and specificity of 90.0% for presence of a DICER1 'hotspot' mutation. PEG10 is a biomarker that is elevated in many DRTP tumors from both sexes bearing a variety of DICER1 'hotspot' variants. PEG10 may act as a cancer-placental antigen/cancer-testis antigen, whose expression could create a possible target for cancer immunotherapies.

    2026
    引用
    AI阅读
    加入学术空间
    4NewFOXC2 Regulates Macrophage Polarization and Osteosarcoma Progression Via Thecxcl12/cxcr4signaling Axis
    Wei Zhao,Yahui Han, Xiaokun Yu, Jianing Liu, Hao Yuan,Juan Li

    Forkhead box protein C2 (FOXC2) is frequently overexpressed in osteosarcoma (OS) and has been implicated in tumor proliferation and metastasis; however, its role in regulating the tumor immune microenvironment remains poorly understood. In this study, integrative bioinformatics analyses of the TCGA-SARC (The Cancer Genome Atlas sarcoma cohort) dataset were performed to evaluate the clinical significance of FOXC2 in OS. High FOXC2 expression was significantly associated with poorer overall survival in patients with OS (p < 0.001). Functional experiments demonstrated that FOXC2 knockdown significantly reduced the overall viable cell/metabolic signal, migration, and invasion in U-2 OS and SaOS-2 cells (p < 0.05). Mechanistically, FOXC2 was found to regulate the CXCL12/CXCR4 signaling axis. ELISA, RT-qPCR, and western blotting analyses showed that FOXC2 knockdown decreased CXCL12 expression, whereas FOXC2 overexpression significantly increased CXCL12 levels. ChIP-qPCR analysis demonstrated significant enrichment of FOXC2 at the CXCL12 promoter and detectable enrichment at the CXCR4 promoter in SaOS-2 cells, and dual-luciferase reporter assays further showed that FOXC2 overexpression significantly increased CXCL12 promoter activity whereas FOXC2 knockdown reduced it, supporting direct transcriptional regulation of the CXCL12/CXCR4 axis by FOXC2. In macrophage co-culture experiments, FOXC2 knockdown promoted M1-like macrophage polarization and reduced M2-like macrophage markers, whereas activation of CXCR4 partially reversed these effects. Flow cytometric analysis further confirmed that FOXC2 knockdown significantly increased the M1/M2 macrophage ratio. In vivo, FOXC2 knockdown markedly reduced tumor growth and lung metastases in a xenograft mouse model, with tumor volume and lung metastatic burden reduced by approximately 50% and 43%, respectively. Tumor tissues from FOXC2-knockdown mice exhibited increased M1-like macrophage infiltration and reduced M2-like macrophage markers. Together, these findings demonstrate that FOXC2 regulates macrophage polarization and OS progression through transcriptional modulation of the CXCL12/CXCR4 signaling axis, highlighting FOXC2 as a potential regulator of the tumor immune microenvironment in OS.

    2026
    引用
    AI阅读
    加入学术空间
    5NewAsymmetric Enzymatic Hydrophosphorylation Through O2 Activation
    Yi Zhou, Yifei Ge,Wesley Harrison,Huimin Zhao

    Enzymatic carbon-phosphorus bond formation is extremely rare in nature, limiting biocatalytic access to phosphorus-containing compounds that are widely used in pharmaceuticals and agrochemicals. Here, we report an asymmetric enzymatic hydrophosphorylation through oxygen activation using a repurposed flavin-dependent enzyme. Mechanistic studies revealed that reactive oxygen species are converted into productive phosphorus-centered radicals, followed by radical addition and enzymatic hydrogen atom transfer, achieving high enantioselectivity. The enzyme accommodates diverse phosphorus-hydrogen donors that pose challenges to chemical catalysis, enabling the biosynthesis of valuable phosphorus-containing scaffolds. This work expands the scope of biocatalysis to programmable carbon-phosphorus bond formation and establishes a paradigm for channeling oxygen reactivity in enzymes.

    2026
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 220359 篇论文

    高被引作者

    作者引用发文
    Andre Geim14700723
    Bert Vogelstein13456870
    Konstantin Sergeevich Novoselov13266419
    Morozov Sergey1055509
    Kenneth W. Kinzler9433052
    Y. Zhang885891
    Da Jiang885891
    S. V. Dubonos885891
    Anatoly Firsov885891
    Eric S. Lander8078839

    高产作者

    作者引用发文
    Eliot Marshall6284645
    Heiner Wedemeyer9740490
    Jeffrey Mervis1403488
    Stefan Zeuzem16693484
    Michael Trauner11366465
    Jon Cohen7564423
    Thomas Berg8206402
    Thomas Reiberger8438388
    Shiv Kumar Sarin6573354
    Christian Trautwein8408352

    相关期刊

    Immunity
    Biochimica et biophysica acta
    Nihon eiseigaku zasshi. Japanese journal of hygiene
    Cell research
    Clinical and translational medicine
    Frontiers in molecular biosciences
    Signal transduction and targeted therapy
    Nature Immunology
    Cell Discovery
    Cell Reports Medicine